- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 814945, 6 pages
PPARα as a Transcriptional Regulator for Detoxification of Plant Diet-Derived Unfavorable Compounds
1Department of Biochemistry, Meiji Pharmaceutical University, 2-522-1 Kiyose, Tokyo 204-8588, Japan
2Central Research Center, Yomeishu Seizo Co., Ltd., Minowa, Nagano 399-4601, Japan
Received 18 December 2011; Revised 5 February 2012; Accepted 26 February 2012
Academic Editor: Annamaria Cimini
Copyright © 2012 Bunichiro Ashibe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. E. Fowler, “Plant poisoning in free-living wild animals: a review,” Journal of Wildlife Diseases, vol. 19, no. 1, pp. 34–43, 1983.
- J. B. Owens, “Genetic aspects of appetite and food choice in animals,” The Journal of Agricultural Science, vol. 119, no. 2, pp. 151–155, 1992.
- D. Y. Mitchell and D. R. Petersen, “Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase,” Archives of Biochemistry and Biophysics, vol. 269, no. 1, pp. 11–17, 1989.
- W. B. Rizzo, E. Heinz, M. Simon, and D. A. Craft, “Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjogren-Larsson syndrome,” Biochimica et Biophysica Acta, vol. 1535, no. 1, pp. 1–9, 2000.
- M. A. Willemsen, J. J. Rotteveel, J. G. de Jong et al., “Defective metabolism of leukotriene B4 in the Sjogren-Larsson syndrome,” Journal of the Neurological Sciences, vol. 183, no. 1, pp. 61–67, 2001.
- T. L. Kelson, S. McVoy Jr., and W. B. Rizzo, “Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization,” Biochimica et Biophysica Acta, vol. 1335, no. 1-2, pp. 99–110, 1997.
- G. A. Jansen, D. M. van den Brink, R. Ofman, O. Draghici, G. Dacremont, and R. J. A. Wanders, “Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid α-oxidation pathway is localized in peroxisomes,” Biochemical and Biophysical Research Communications, vol. 283, no. 3, pp. 674–679, 2001.
- K. Motojima and T. Hirai, “Peroxisome proliferator-activated receptor α plays a vital role in inducing a detoxification system against plant compounds with crosstalk with other xenobiotic nuclear receptors,” The FEBS Journal, vol. 273, no. 2, pp. 292–300, 2006.
- O. Barbier, D. Duran-Sandoval, I. Pineda-Torra, V. Kosykh, J. C. Fruchart, and B. Staels, “The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor α and γ target gene,” Journal of Biological Chemistry, vol. 278, pp. 13975–13983, 2003.
- S. S. T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the α isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995.
- S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999.
- K. Motojima, “17β-hydroxysteroid dehydrogenase type 11 is a major peroxisome proliferator-activated receptor α-regulated gene in mouse intestine,” European Journal of Biochemistry, vol. 271, no. 20, pp. 4141–4146, 2004.
- R. Mindnich, G. Moller, and J. Adamski, “The role of 17β-hydroxysteroid dehydrogenases,” Molecular and Cellular Endocrinology, vol. 218, pp. 7–20, 2004.
- N. Shafqat, H. U. Marschall, C. Filling et al., “Expanded substrate screenings of human and Drosophila type 10 17 β-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3α/7α/7β/17β/20β/21-HSD,” Biochemical Journal, vol. 376, no. 1, pp. 49–60, 2003.
- G. J. Kapadia, M. A. Azuine, H. Tokuda et al., “Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis,” Pharmacological Research, vol. 45, no. 6, pp. 499–505, 2002.
- D. Nakano, D. Kurumazuka, Y. Nagai, A. Nishiyama, Y. Kiso, and Y. Matsumura, “Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 3, pp. 324–326, 2008.
- H. Aishan, Y. Horiguchi, and K. Motojima, “Physiologic roles of hepatic lipid droplets and involvement of peroxisome proliferator-activated receptor α in their dynamism,” Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 351–354, 2010.
- F. Djouadi, C. J. Weinheimer, J. E. Saffitz et al., “A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice,” Journal of Clinical Investigation, vol. 102, no. 6, pp. 1083–1091, 1998.
- L. P. Duan, H. H. Wang, A. Ohashi, and D. Q. H. Wang, “Role ofintestinal sterol transporters Abcg5, and Npc111 in cholesterol absorption in mice: gender and age effects,” American Journal Of Physiology, vol. 290, no. 2, part 1, pp. G269–G276, 2006.
- D. Demozay, S. Rocchi, J. C. Mas et al., “Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 6261–6270, 2004.
- B. Ashibe, T. Hirai, K. Higashi, K. Sekimizu, and K. Motojima, “Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing,” Journal of Biological Chemistry, vol. 282, no. 28, pp. 20763–20773, 2007.
- B. Ashibe and K. Motojima, “Fatty aldehyde dehydrogenase is up-regulated by polyunsaturated fatty acid via peroxisome proliferator-activated receptor α and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress,” The FEBS Journal, vol. 276, no. 23, pp. 6956–6970, 2009.
- A. D. Haegele, S. P. Briggs, and H. J. Thompson, “Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage,” Free Radical Biology and Medicine, vol. 16, no. 1, pp. 111–115, 1994.
- C. Feillet-Coudray, E. Rock, C. Coudray et al., “Lipid peroxidation and antioxidant status in experimental diabetes,” Clinica Chimica Acta, vol. 284, no. 1, pp. 31–43, 1999.
- Y. Yokoi, Y. Horiguchi, M. Araki, and K. Motojima, “Regulated expression by PPARα and unique localization of 17β-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver,” The FEBS Journal, vol. 274, no. 18, pp. 4837–4847, 2007.
- Y. Horiguchi, M. Araki, and K. Motojima, “Identificsation and characterization of the ER/lipid droplet-targeting sequence in 17β-hydroxysteroid dehydrogenase type 11,” Archives of Biochemistry and Biophysics, vol. 479, no. 2, pp. 121–130, 2008.
- E. M. van Lieshout, M. M. Bedaf, M. Pieter, C. Ekkel, W. A. Nijhoff, and W. H. Peters, “Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels,” Carcinogenesis, vol. 19, no. 11, pp. 2055–2057, 1998.
- S. Ohno, N. Matsumoto, M. Watanabe, and S. Nakajin, “Flavonoid inhibition of overexpressed human 3β-hydroxysteroid dehydrogenase type II,” Journal of Steroid Biochemistry and Molecular Biology, vol. 88, no. 2, pp. 175–182, 2004.
- N. F. Shay and W. J. Banz, “Regulation of gene transcription by botanicals: novel regulatory mechanisms,” Annual Review of Nutrition, vol. 25, pp. 297–315, 2005.
- S. S. Ferguson, E. L. Lecluyse, M. Negishi, and J. A. Goldstein, “Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site,” Molecular Pharmacology, vol. 62, no. 3, pp. 737–746, 2002.
- J. M. Pascussi, S. Gerbal-Chaloin, L. Drocourt, P. Maurel, and M. J. Vilarem, “The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors,” Biochimica et Biophysica Acta, vol. 1619, no. 3, pp. 243–253, 2003.
- J. P. Jackson, S. S. Ferguson, R. Moore, M. Negishi, and J. A. Goldstein, “The constitutive active/androstane receptor regulates phenytoin induction of Cyp2c29,” Molecular Pharmacology, vol. 65, no. 6, pp. 1397–1404, 2004.
- S. P. Anderson, C. Dunn, A. Laughter et al., “Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor α, retinoid X receptor, and liver X receptor in mouse liver,” Molecular Pharmacology, vol. 66, no. 6, pp. 1440–1452, 2004.
- S. Gerbal-Chaloin, J. M. Pascussi, L. Pichard-Garcia et al., “Induction of CYP2C genes in human hepatocytes in primary culture,” Drug Metabolism and Disposition, vol. 29, no. 3, pp. 242–251, 2001.
- D. W. Nebert, T. P. Dalton, A. B. Okey, and F. J. Gonzalez, “Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 23847–23850, 2004.
- K. W. Bock and C. Köhle, “Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters,” Drug Metabolism Reviews, vol. 36, no. 3-4, pp. 595–615, 2004.
- C. Xu, C. Y. Li, and A. N. Kong, “Induction of phase I, II and III drug metabolism/transport by xenobiotics,” Archives of Pharmacal Research, vol. 28, no. 3, pp. 249–268, 2005.
- O. Barbier, C. Fontaine, J. C. Fruchart, and B. Staels, “Genomic and non-genomic interactions of PPARα with xenobiotic-metabolizing enzymes,” Trends in Endocrinology and Metabolism, vol. 15, no. 7, pp. 324–330, 2004.
- W. Xie, J. L. Barwick, C. M. Simon et al., “Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR,” Genes and Development, vol. 14, no. 23, pp. 3014–3023, 2000.
- K. W. Bock and C. Kohle, “Coodinate regulation of drug metabolism by xenobioticnuclear receptors: UGTs acting together with CYPs and glucronide transporters,” Drug Metabolism Reviews, vol. 36, no. 3-4, pp. 595–615, 2004.